n-nitrosothiazolidine-4-carboxylic acid and Hyperparathyroidism, Primary

n-nitrosothiazolidine-4-carboxylic acid has been researched along with Hyperparathyroidism, Primary in 1 studies

*Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Borderie, D; Clerc, J; Cochand-Priollet, B; Cormier, C; Delbot, T; Gaujoux, S; Gauthé, M; Koumakis, E; Martinino, A; Roux, C; Sindayigaya, R; Wartski, M	1

Other Studies

1 other study(ies) available for n-nitrosothiazolidine-4-carboxylic acid and Hyperparathyroidism, Primary

Article	Year
FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography. The Journal of clinical endocrinology and metabolism, 2023, Jul-14, Volume: 108, Issue:8 Topics: Calcium; Choline; Humans; Hyperparathyroidism, Primary; Organotechnetium Compounds; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Ultrasonography	2023

Article

Year

FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.

The Journal of clinical endocrinology and metabolism, 2023, Jul-14, Volume: 108, Issue:8

Topics: Calcium; Choline; Humans; Hyperparathyroidism, Primary; Organotechnetium Compounds; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Ultrasonography

2023